Moleculin Biotech, Inc. (MBRX)
NASDAQ: MBRX · Real-Time Price · USD
2.730
-0.100 (-3.53%)
Nov 22, 2024, 4:00 PM EST - Market closed
Moleculin Biotech Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2015 |
---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2015 |
Cash & Equivalents | 9.41 | 23.55 | 43.15 | 70.9 | 15.17 | 10.74 | Upgrade
|
Cash & Short-Term Investments | 9.41 | 23.55 | 43.15 | 70.9 | 15.17 | 10.74 | Upgrade
|
Cash Growth | -61.74% | -45.42% | -39.15% | 367.30% | 41.34% | 50.48% | Upgrade
|
Other Receivables | - | 0.1 | 0.02 | 0.05 | 0 | 0.01 | Upgrade
|
Receivables | - | 0.1 | 0.02 | 0.05 | 0 | 0.01 | Upgrade
|
Prepaid Expenses | 2.2 | 2.08 | 1.63 | 1.06 | 0.74 | 0.35 | Upgrade
|
Other Current Assets | - | 0.55 | 0.8 | 0.49 | 1.28 | 2.39 | Upgrade
|
Total Current Assets | 11.61 | 26.27 | 45.6 | 72.5 | 17.2 | 13.48 | Upgrade
|
Property, Plant & Equipment | 0.64 | 0.8 | 0.68 | 0.45 | 0.69 | 0.6 | Upgrade
|
Other Intangible Assets | 11.15 | 11.15 | 11.15 | 11.15 | 11.15 | 11.15 | Upgrade
|
Total Assets | 23.39 | 38.22 | 57.42 | 84.09 | 29.03 | 25.24 | Upgrade
|
Accounts Payable | 2.55 | 2.5 | 2.1 | 1.36 | 1.13 | 2.15 | Upgrade
|
Accrued Expenses | 2.93 | 4.22 | 2.61 | 2.16 | 1.67 | 1.22 | Upgrade
|
Current Portion of Leases | 0.12 | 0.1 | 0.12 | 0.1 | 0.12 | 0.1 | Upgrade
|
Other Current Liabilities | - | - | - | - | - | 0.1 | Upgrade
|
Total Current Liabilities | 5.59 | 6.82 | 4.82 | 3.62 | 2.92 | 3.57 | Upgrade
|
Long-Term Leases | 0.39 | 0.47 | 0.34 | 0.06 | 0.16 | 0.28 | Upgrade
|
Other Long-Term Liabilities | 9.93 | 4.86 | 0.08 | 1.41 | 8.19 | 5.82 | Upgrade
|
Total Liabilities | 15.92 | 12.14 | 5.23 | 5.1 | 11.27 | 9.66 | Upgrade
|
Common Stock | 0 | 0.03 | 0.03 | 0.03 | 0.07 | 0.05 | Upgrade
|
Additional Paid-In Capital | 158.96 | 157.65 | 153.99 | 151.73 | 74.67 | 55.06 | Upgrade
|
Retained Earnings | -151.49 | -131.6 | -101.84 | -72.81 | -56.92 | -39.56 | Upgrade
|
Comprehensive Income & Other | 0 | -0.01 | 0.01 | 0.04 | -0.06 | 0.03 | Upgrade
|
Shareholders' Equity | 7.48 | 26.07 | 52.19 | 78.99 | 17.76 | 15.57 | Upgrade
|
Total Liabilities & Equity | 23.39 | 38.22 | 57.42 | 84.09 | 29.03 | 25.24 | Upgrade
|
Total Debt | 0.51 | 0.57 | 0.45 | 0.16 | 0.28 | 0.38 | Upgrade
|
Net Cash (Debt) | 8.9 | 22.98 | 42.69 | 70.74 | 14.9 | 10.36 | Upgrade
|
Net Cash Growth | -62.91% | -46.18% | -39.65% | 374.92% | 43.84% | 45.16% | Upgrade
|
Net Cash Per Share | 3.31 | 11.63 | 22.39 | 39.48 | 22.69 | 22.89 | Upgrade
|
Filing Date Shares Outstanding | 3 | 2.23 | 1.91 | 1.91 | 1.9 | 0.59 | Upgrade
|
Total Common Shares Outstanding | 3 | 2.23 | 1.91 | 1.91 | 0.77 | 0.51 | Upgrade
|
Working Capital | 6.01 | 19.46 | 40.78 | 68.88 | 14.28 | 9.91 | Upgrade
|
Book Value Per Share | 2.49 | 11.70 | 27.35 | 41.46 | 23.09 | 30.65 | Upgrade
|
Tangible Book Value | -3.67 | 14.93 | 41.04 | 67.85 | 6.61 | 4.42 | Upgrade
|
Tangible Book Value Per Share | -1.22 | 6.70 | 21.51 | 35.61 | 8.60 | 8.71 | Upgrade
|
Machinery | - | 1.17 | 1.04 | 0.98 | 0.96 | 0.6 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.